General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now? | news.google.com • |
Cloudflare Stock Tumbles As Revenue Outlook Underwhelms Investors | news.google.com • |
US Stock Market Outlook and Valuation for May 2024 | news.google.com • |
Cloudflare Stock Plunges as Sales Outlook Disappoints—Monitor This Key Price Level | news.google.com • |
Tesla Stock Outlook: Why the Latest TSLA News Hardly Changes the Story | news.google.com • |
Cloudflare stock plummets as revenue outlook underwhelms | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-20 | 2024-03 | -0.88 | N/A | N/A | N/A |
2024-02-14 | 2023-12 | -1 | -0.8 | 0.2 | 20.00% |
2023-12-22 | 2023-09 | -1 | -1 | N/A | N/A |
2023-08-14 | 2023-06 | -0.8 | -1.6 | -0.8 | -100.00% |
2023-05-15 | 2023-03 | -1.2 | -0.6 | 0.6 | 50.00% |
2023-02-14 | 2022-12 | -0.8 | -1.6 | -0.8 | -100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Chardan Capital | Downgrade | Buy | Neutral |
2023-08-30 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-08-29 | Brookline Capital | Downgrade | Buy | Hold |
2023-08-29 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
2023-08-29 | BTIG | Downgrade | Buy | Neutral |
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-04-19 | DAGNON TERRY | Chief Operating Officer | 653.06K | Sale |
2024-03-06 | EVANSON JEFF | Officer | 808.46K | Purchase |
2024-03-27 | HADDADIN YEZAN MUNTHER | Director | 5.05K | Purchase |
2022-10-04 | HILZINGER KURT J | Director | 473.12K | Purchase |
2021-04-19 | KENYON LAWRENCE A. | Chief Executive Officer | 18.93K | Purchase |
2022-10-06 | SUKHTIAN FAISAL GHIATH | Director | 68.00K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 9.22M | 16.04M | 3.54% |
2023-06-29 | Vanguard Group Inc | 6.15M | 10.70M | 2.36% |
2023-06-29 | State Street Corporation | 2.75M | 4.79M | 1.06% |
2023-06-29 | Geode Capital Management, LLC | 2.72M | 4.73M | 1.05% |
2023-06-29 | Northern Trust Corporation | 1.26M | 2.18M | 0.48% |
2023-06-29 | Nuveen Asset Management, LLC | 598.96K | 1.04M | 0.23% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.61M | 6.28M | 1.39% |
2023-08-30 | iShares Russell 2000 ETF | 3.58M | 815.24K | 1.37% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.45M | 2.52M | 0.56% |
2023-07-30 | Fidelity Small Cap Index Fund | 1.38M | 2.38M | 0.53% |
2023-08-30 | iShares Russell 2000 Growth ETF | 1.27M | 289.29K | 0.49% |
2023-05-30 | Fidelity Extended Market Index Fund | 519.75K | 779.62K | 0.20% |
Split | Date |
---|---|
1 : 20 | 2024-03-14 |
1 : 8 | 2019-03-18 |
It may be that the system is capable of beating this one down… so it is doing it. Remember EMA and FDA want this medication approved so it stops: compounding, impurities, particulates, and lack of drug potency. I appreciate/capitalizing on the bargain pricing.
Old news and already built into the price.
Frank, you selling short only creates shares you will have to cover later. When you are done in the kiddy sand box.… come play with the real investors. Price doesn't reflect value at this time.
The current price does not reflect its value. It is simply a reflection of daytraders and shorts upon the approval of EMA revenue will begin to be produced and an entirely different class of investor will be coming to the stock. Which point price corrections will begin to accelerate forward based on prebuilt market, and future revenues.
Syntone Ventures LLC is a major pharma distributor in the EU……just a little foreshadowing of things to come!
Waldo_III, that is your dumbest post yet. Hard to treat you like an experienced investor.
Let’s be “Frank”. First of all, no thanks!! Agitators are better suited for washing machines. “Short sided” traders will be taken to the cleaners soon. However their soiled under garments will be hard to clean. The final count down is near….$60 dollars by year’s end!
Frank, you keep saying garbage, but after all these years, you’re still here try to explain that one to us
Frank ~ go educate yourself. No one wants to read your outlandish statements. we prefer to deal with people that work in facts.
Just another day of shorts selling to shorts. True ling investors have not lost any money. True longs don't gamble on emotional daily swings. The real money is in bringing this product to market. Today's price diesnotvreforct the real value. Be patient and hold, approval is only days away.
I just bought me some more shares from a crazy short. I sure love getting good deals.
Isn't interesting how the shorts can always find a buyer at this price. I wonder if they think there will be sellers when the EU approval comes in a few days… like France Chance said it will be a lot of easy money for the longs. Sorry shorts you arecraking one to many rounds on the dance floor. You are going to play the fiddler his due.
Mbappe, the only problem with 10% market capture is that it doesn't factor in market exclusivity. Upon approval all off label must stop due to patent exclusivity. Simply put patients can convert or go blind. I don't know pricing but believe the increase in price will still leave this the least approved therapy on market. I believe 100% of compounding business will be captured
Frank Chance, you are a long way from th$7.00 short sale. Get out before you lose your house. Pride is going to cost you dearly here. Just admit you got this one wrong.
Bernie Forrester, future revenue should cap out at about $200-300 a share with current market information. There is about another year and a half to wait. Patience is a virtue.